Clinical-stage biopharmaceutical company developing precision oncology therapeutics, including taletrectinib for ROS1 fusion-positive NSCLC. Acquired by Nuvation Bio in 2024.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
